C07C 49/24
Containing hydroxy groups
Official title: containing hydroxy groups
C07C49/24 (Containing hydroxy groups) appears on 213 US grants and 138 published applications in this corpus.
Search patents in C07C- Granted patents
- 213
- Published applications
- 138
- Assignees
- 185
- Inventors
- 634
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 10 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 13 | 0 |
| 1990 | 8 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 8 | 0 |
| 1994 | 10 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 3 |
| 2003 | 4 | 7 |
| 2004 | 4 | 8 |
| 2005 | 5 | 12 |
| 2006 | 7 | 1 |
| 2007 | 8 | 8 |
| 2008 | 5 | 6 |
| 2009 | 5 | 5 |
| 2010 | 6 | 8 |
| 2011 | 1 | 6 |
| 2012 | 6 | 5 |
| 2013 | 6 | 4 |
| 2014 | 4 | 7 |
| 2015 | 5 | 6 |
| 2016 | 9 | 5 |
| 2017 | 6 | 3 |
| 2018 | 3 | 6 |
| 2019 | 2 | 8 |
| 2020 | 5 | 9 |
| 2021 | 5 | 7 |
| 2022 | 4 | 9 |
| 2023 | 3 | 1 |
| 2024 | 6 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for inhibiting blood cancer cell growth21 Apr 2026US 12,605,352 B2University of New Brunswick
- Fatty acid derivatives and their use25 Nov 2025US 12,479,812 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Inhibitors of the n-terminal domain of the androgen receptor10 Dec 2024US 12,162,818 B2The Regents of the University of California
- Half-curcuminoids as amyloid-β PET imaging agents12 Nov 2024US 12,138,321 B2The General Hospital Corporation
- Amarouciaxanthin A esters and uses thereof29 Oct 2024US 12,129,229 B2Gat Therapeutics, S.L.
- Estrogenic compounds and methods of use17 Jul 2025US 2025/0228795 A1
- Compounds having s1p5 receptor agonistic activity3 Oct 2024US 2024/0327342 A1Ono Pharmaceutical Co., Ltd.
- Amarouciaxanthin a esters and uses thereof18 Jul 2024US 2024/0239733 A1Gat Therapeutics, S.L.
- Substituted aromatic compounds and pharmaceutical compositions thereof8 Feb 2024US 2024/0043372 A1Pharmaceutique Ingenew Inc.
- Methods of using andrographolide, oridonin and isoliquiritigenin and derivatives thereof2 Mar 2023US 2023/0069586 A1The Regents of the University of California
Most cited
By later US patents
- Naphthalene derivatives having retinoid type action, the process for preparation thereof and medicinal and cosmetic compositions containing them104US 4,879,284 AL'oreal · 1989
- Methods and compositions for regulation of 5-α-reductase activity97US 6,576,660 B1Arch Development Corporation · 2003
- Ketone compounds and compositions for cholesterol management and related uses56US 6,699,910 B2Esperion Therapeutics, Inc. · 2004
- Method and compositions for regulation of 5-alpha reductase activity55US 6,696,484 B2University of Chicago Office of Technology and Intellectual Property · 2004
- Signal enhancement in immunoassay by modulation of enzymatic catalysis39US 4,835,099 ABecton, Dickinson and Company · 1989